e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status
Anna Stupnytska (Chernivtsi, Ukraine), Ganna Stupnytska, Anastasiya Stupnytska, Olga Pritulyak, Olga Nesterovska
Source:
International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Session:
Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Session type:
Poster Discussion
Number:
3004
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anna Stupnytska (Chernivtsi, Ukraine), Ganna Stupnytska, Anastasiya Stupnytska, Olga Pritulyak, Olga Nesterovska. The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status. Eur Respir J 2015; 46: Suppl. 59, 3004
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Some gender features of the chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD treatment
Year: 2013
To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
The decrease of nutritional status and increasing of the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Early phenotypes of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Different data in COPD
Year: 2015
Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Study assoicção between severity stages of chronic obstructive pulmonary disease and fasting glucose in patients with this disease
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013
Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline?
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Prevalence of vitamin D deficiency in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
Early discharge for patients with exacerbations of COPD - a real life cohort study
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005
Anxiety and low health status are predictors of exacerbations in patients with obstructive pulmonary disease
Source: Annual Congress 2006 - Muscles, training and rehabilitation
Year: 2006
Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept